EUVIMEDEUVIMED entdecken
Open Access

Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates

Qian-Fang Meng iD, Wanbo Tai iD, Mingyao Tian iD, Xinyu Zhuang iD, Yuanwei Pan, Jialin Lai, Yangtao Xu iD, Zhiqiang Xu, Min Li iD, Guangyu Zhao iD, Guang-Tao Yu iD, Guocan Yu iD und 6 weitere

Science Advances · 16.06.2023 · 9 (24)

DOI: 10.1126/sciadv.adg3277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 16.06.2023. Verfasst von Qian-Fang Meng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518132, China. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dexamethasone (DEX) is the first drug to show life-saving efficacy in patients with severe coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse effects. Here, we report an inhaled, Self-immunoregulatory, Extracellular Nanovesicle-based Delivery (iSEND) system by engineering neutrophil nanovesicles with cholesterols to deliver DEX for enhanced treatment of COVID-19. Relying on surface chemokine and cytokine receptors, the iSEND showed improved targeting to macrophages and neutralized broad-spectrum cytokines. The nanoDEX, made by encapsulating DEX with the iSEND, efficiently promoted the anti-inflammation effect of DEX in an acute pneumonia mouse model and suppressed DEX-induced bone density reduction in an osteoporosis rat model. Relative to an intravenous administration of DEX at 0.1 milligram per kilogram, a 10-fold lower dose of nanoDEX administered by inhalation produced even better effects against lung inflammation and injury in severe acute respiratory syndrome coronavirus 2–challenged nonhuman primates. Our work presents a safe and robust inhalation delivery platform for COVID-19 and other respiratory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NanoparticlesMiceRatsAnimalsCytokine Release SyndromeCOVID-19 Drug TreatmentDexamethasonePrimates

Substanzen

Dexamethasone

Autor:innen und Institutionen

  • Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.
  • Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun 130122, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
  • State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

ORCID-Profile: Qian-Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yangtao Xu, Min Li, Guangyu Zhao, Guang-Tao Yu, Guocan Yu, Ningyi Jin, Xiao Li, Gong Cheng, Xiaoyuan Chen, Lang Rao

Zitieren

APA

Meng, Q. F., Tai, W., Tian, M., Zhuang, X., Pan, Y., Lai, J., Xu, Y., Xu, Z., Li, M., Zhao, G., Yu, G. T., Yu, G., Chen, R., Jin, N., Li, X., Cheng, G., Chen, X., & Rao, L. (2023). Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Science Advances, 9(24). https://doi.org/10.1126/sciadv.adg3277

Vancouver

Meng QF, Tai W, Tian M, Zhuang X, Pan Y, Lai J, et al. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Science Advances. 2023;9(24). doi:10.1126/sciadv.adg3277

BibTeX
@article{Meng2023,
  author = {Meng, Qian-Fang and Tai, Wanbo and Tian, Mingyao and Zhuang, Xinyu and Pan, Yuanwei and Lai, Jialin and Xu, Yangtao and Xu, Zhiqiang and Li, Min and Zhao, Guangyu and Yu, Guang-Tao and Yu, Guocan and Chen, Rongchang and Jin, Ningyi and Li, Xiao and Cheng, Gong and Chen, Xiaoyuan and Rao, Lang},
  title = {Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {24},
  doi = {10.1126/sciadv.adg3277}
}
Kostenlos starten →